Combination Therapy Shows Potential in Psoriasis, Obesity - Top-Institutions - MDSpire

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

  • By

  • Kathryn Wighton

  • May 20, 2026

  • 5 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, NY

    Key Differentiators

    • Dermatology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Dermatology

  • #3

    National Psoriasis Foundation Medical Board
    National Psoriasis Foundation Medical Board

    Portland, OR

    Key Differentiators

    • Dermatology

  • #4

    University of Alabama at Birmingham
    University of Alabama at Birmingham

    Birmingham, AL

    Key Differentiators

    • Dermatology

  • #5

    University of California Los Angeles
    University of California Los Angeles

    Los Angeles, CA

    Key Differentiators

    • Dermatology

Original Source(s)

Combination Therapy Shows Potential in Psoriasis, Obesity

  • by Kathryn Wighton

  • May 20, 2026

Related Content

Dermatologic Conditions and Incident Anxiety in Young Adults: Propensity Score–Matched Retrospective Cohort Study

The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics

Navigating renal safety in the biologic treatment of psoriasis: from immunologic mechanisms to clinical practice